

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit biogenesis (GO:0042274) | 5.54162627 |
| 2 | viral transcription (GO:0019083) | 4.68945529 |
| 3 | modulation by virus of host process (GO:0019054) | 4.64356103 |
| 4 | L-serine metabolic process (GO:0006563) | 4.49276141 |
| 5 | modulation by symbiont of host cellular process (GO:0044068) | 4.34809516 |
| 6 | ribosomal small subunit assembly (GO:0000028) | 4.31590431 |
| 7 | translational termination (GO:0006415) | 4.28263655 |
| 8 | translational elongation (GO:0006414) | 4.01403413 |
| 9 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.89389945 |
| 10 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.77953463 |
| 11 | viral life cycle (GO:0019058) | 3.77109761 |
| 12 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.70264334 |
| 13 | pentose-phosphate shunt (GO:0006098) | 3.68121467 |
| 14 | NIK/NF-kappaB signaling (GO:0038061) | 3.67976601 |
| 15 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.66621303 |
| 16 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.62515694 |
| 17 | ncRNA 3-end processing (GO:0043628) | 3.59563682 |
| 18 | modulation by symbiont of host immune response (GO:0052553) | 3.58564512 |
| 19 | positive regulation by symbiont of host defense response (GO:0052509) | 3.58564512 |
| 20 | modulation by symbiont of host defense response (GO:0052031) | 3.58564512 |
| 21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.58564512 |
| 22 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.58564512 |
| 23 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.58564512 |
| 24 | activation of MAPKKK activity (GO:0000185) | 3.45155760 |
| 25 | histone arginine methylation (GO:0034969) | 3.44010827 |
| 26 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.39913476 |
| 27 | NADPH regeneration (GO:0006740) | 3.30064684 |
| 28 | adenine nucleotide transport (GO:0051503) | 3.28663138 |
| 29 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.26865638 |
| 30 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 3.25493531 |
| 31 | cellular protein complex disassembly (GO:0043624) | 3.25486667 |
| 32 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.25364152 |
| 33 | protein targeting to ER (GO:0045047) | 3.22453378 |
| 34 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.19210856 |
| 35 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.18622906 |
| 36 | protein complex disassembly (GO:0043241) | 3.18111304 |
| 37 | immunoglobulin mediated immune response (GO:0016064) | 3.14915859 |
| 38 | cotranslational protein targeting to membrane (GO:0006613) | 3.11837104 |
| 39 | pentose metabolic process (GO:0019321) | 3.10253126 |
| 40 | positive regulation of protein homooligomerization (GO:0032464) | 3.06461320 |
| 41 | protein localization to endoplasmic reticulum (GO:0070972) | 3.05751738 |
| 42 | maturation of SSU-rRNA (GO:0030490) | 3.05331593 |
| 43 | serine family amino acid biosynthetic process (GO:0009070) | 3.05210349 |
| 44 | peptidyl-arginine N-methylation (GO:0035246) | 3.04417323 |
| 45 | peptidyl-arginine methylation (GO:0018216) | 3.04417323 |
| 46 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.04097552 |
| 47 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.02598810 |
| 48 | positive thymic T cell selection (GO:0045059) | 2.98139509 |
| 49 | purine ribonucleotide transport (GO:0015868) | 2.96593225 |
| 50 | negative regulation of interleukin-12 production (GO:0032695) | 2.93970659 |
| 51 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.92541448 |
| 52 | negative regulation of phagocytosis (GO:0050765) | 2.88734690 |
| 53 | cellular response to virus (GO:0098586) | 2.87364221 |
| 54 | post-embryonic morphogenesis (GO:0009886) | 2.87181552 |
| 55 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.86595749 |
| 56 | deoxyribonucleotide catabolic process (GO:0009264) | 2.84819264 |
| 57 | negative regulation of B cell apoptotic process (GO:0002903) | 2.84415100 |
| 58 | thymic T cell selection (GO:0045061) | 2.83996431 |
| 59 | macromolecular complex disassembly (GO:0032984) | 2.82626559 |
| 60 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.81016215 |
| 61 | translational initiation (GO:0006413) | 2.80090062 |
| 62 | response to protozoan (GO:0001562) | 2.79445301 |
| 63 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.76217127 |
| 64 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.75248865 |
| 65 | nucleosome disassembly (GO:0006337) | 2.74091103 |
| 66 | protein-DNA complex disassembly (GO:0032986) | 2.74091103 |
| 67 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.73271640 |
| 68 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.73016736 |
| 69 | glucose catabolic process (GO:0006007) | 2.69775119 |
| 70 | B cell mediated immunity (GO:0019724) | 2.67038669 |
| 71 | positive regulation of protein oligomerization (GO:0032461) | 2.65865035 |
| 72 | deoxyribose phosphate catabolic process (GO:0046386) | 2.65629496 |
| 73 | response to muramyl dipeptide (GO:0032495) | 2.60931894 |
| 74 | negative regulation of amino acid transport (GO:0051956) | 2.59024827 |
| 75 | modulation by virus of host morphology or physiology (GO:0019048) | 2.58264602 |
| 76 | regulation of podosome assembly (GO:0071801) | 2.57714796 |
| 77 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.56170227 |
| 78 | regulation of B cell apoptotic process (GO:0002902) | 2.55693618 |
| 79 | cellular response to interleukin-4 (GO:0071353) | 2.55235389 |
| 80 | response to peptidoglycan (GO:0032494) | 2.54968186 |
| 81 | negative regulation of granulocyte differentiation (GO:0030853) | 2.54592211 |
| 82 | cellular hyperosmotic response (GO:0071474) | 2.53230178 |
| 83 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.53160814 |
| 84 | regulation of release of cytochrome c from mitochondria (GO:0090199) | 2.51215643 |
| 85 | mitochondrial fusion (GO:0008053) | 2.51204472 |
| 86 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.50291210 |
| 87 | response to interleukin-4 (GO:0070670) | 2.49627630 |
| 88 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.49143329 |
| 89 | UV protection (GO:0009650) | 2.48665155 |
| 90 | histone H3-K36 demethylation (GO:0070544) | 2.48503948 |
| 91 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.47215765 |
| 92 | type I interferon signaling pathway (GO:0060337) | 2.45737993 |
| 93 | cellular response to type I interferon (GO:0071357) | 2.45737993 |
| 94 | negative regulation of RNA splicing (GO:0033119) | 2.45455736 |
| 95 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.44923302 |
| 96 | heterochromatin organization (GO:0070828) | 2.44798554 |
| 97 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.43781138 |
| 98 | establishment of mitochondrion localization (GO:0051654) | 2.43641417 |
| 99 | regulation of mitochondrial membrane permeability (GO:0046902) | 2.43345917 |
| 100 | regulation of protein heterodimerization activity (GO:0043497) | 2.42781069 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.11107099 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 3.02270729 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.80434563 |
| 4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.58763551 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.56114919 |
| 6 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.31320321 |
| 7 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.29760570 |
| 8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.20296525 |
| 9 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.19389467 |
| 10 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 2.02264168 |
| 11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.89008556 |
| 12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.83246965 |
| 13 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.77899867 |
| 14 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.77771902 |
| 15 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.77466979 |
| 16 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.74537004 |
| 17 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.73525788 |
| 18 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.72294600 |
| 19 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.69903039 |
| 20 | P68_20966046_ChIP-Seq_HELA_Human | 1.69398792 |
| 21 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68514228 |
| 22 | UTX_26944678_Chip-Seq_JUKART_Human | 1.68498268 |
| 23 | MAF_26560356_Chip-Seq_TH2_Human | 1.65959844 |
| 24 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.65717422 |
| 25 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.65045624 |
| 26 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.64866723 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.64065186 |
| 28 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.60212581 |
| 29 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.59892020 |
| 30 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.55900960 |
| 31 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.54928681 |
| 32 | MAF_26560356_Chip-Seq_TH1_Human | 1.54354954 |
| 33 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.53134341 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.52664388 |
| 35 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.51482262 |
| 36 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.50306072 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.47980164 |
| 38 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.46383840 |
| 39 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.45930394 |
| 40 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.45723553 |
| 41 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.44573347 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.44394986 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44093228 |
| 44 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.43557231 |
| 45 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.41420627 |
| 46 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.41057896 |
| 47 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40875688 |
| 48 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.39904815 |
| 49 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.39342732 |
| 50 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.39135574 |
| 51 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.37077000 |
| 52 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.36318858 |
| 53 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.32577884 |
| 54 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.30284915 |
| 55 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.27729030 |
| 56 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.27384379 |
| 57 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.27113091 |
| 58 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.25488948 |
| 59 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.23425881 |
| 60 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.22625494 |
| 61 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.22614592 |
| 62 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21714380 |
| 63 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.20416227 |
| 64 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.19844712 |
| 65 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.19512405 |
| 66 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.19496771 |
| 67 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.19381909 |
| 68 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.19115563 |
| 69 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.18755208 |
| 70 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.18170975 |
| 71 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.17770265 |
| 72 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.15159733 |
| 73 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.15000600 |
| 74 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.14558850 |
| 75 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.13773338 |
| 76 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.13561910 |
| 77 | SA1_27219007_Chip-Seq_Bcells_Human | 1.13463321 |
| 78 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.13061731 |
| 79 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.12684109 |
| 80 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.11736894 |
| 81 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.11211523 |
| 82 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.10985039 |
| 83 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.10532242 |
| 84 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.10427872 |
| 85 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.10111382 |
| 86 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.09961300 |
| 87 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.09711436 |
| 88 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.08533456 |
| 89 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07757886 |
| 90 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.07270187 |
| 91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05819901 |
| 92 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.04773221 |
| 93 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.04419856 |
| 94 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.04299224 |
| 95 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.04173713 |
| 96 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04038095 |
| 97 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03878156 |
| 98 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.02918976 |
| 99 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.02207907 |
| 100 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.02114124 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009278_abnormal_bone_marrow | 3.90678884 |
| 2 | MP0002254_reproductive_system_inflammat | 3.89673822 |
| 3 | MP0003303_peritoneal_inflammation | 3.60321561 |
| 4 | MP0002138_abnormal_hepatobiliary_system | 3.07422394 |
| 5 | MP0005058_abnormal_lysosome_morphology | 2.80687807 |
| 6 | MP0003436_decreased_susceptibility_to | 2.53751476 |
| 7 | MP0001545_abnormal_hematopoietic_system | 2.53452064 |
| 8 | MP0005397_hematopoietic_system_phenotyp | 2.53452064 |
| 9 | MP0006292_abnormal_olfactory_placode | 2.51729903 |
| 10 | MP0000685_abnormal_immune_system | 2.34963747 |
| 11 | MP0001849_ear_inflammation | 2.19641076 |
| 12 | MP0005671_abnormal_response_to | 2.16561218 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.15719073 |
| 14 | MP0001800_abnormal_humoral_immune | 2.12747990 |
| 15 | MP0001790_abnormal_immune_system | 2.11242139 |
| 16 | MP0005387_immune_system_phenotype | 2.11242139 |
| 17 | MP0002653_abnormal_ependyma_morphology | 2.02704573 |
| 18 | MP0005025_abnormal_response_to | 1.98299075 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 1.96826800 |
| 20 | MP0001835_abnormal_antigen_presentation | 1.95944389 |
| 21 | MP0009785_altered_susceptibility_to | 1.92779467 |
| 22 | MP0009840_abnormal_foam_cell | 1.89434186 |
| 23 | MP0002452_abnormal_antigen_presenting | 1.84823464 |
| 24 | MP0002723_abnormal_immune_serum | 1.83087269 |
| 25 | MP0002419_abnormal_innate_immunity | 1.78688100 |
| 26 | MP0002420_abnormal_adaptive_immunity | 1.78584755 |
| 27 | MP0001819_abnormal_immune_cell | 1.77305989 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 1.72809791 |
| 29 | MP0000490_abnormal_crypts_of | 1.71181377 |
| 30 | MP0005394_taste/olfaction_phenotype | 1.69490362 |
| 31 | MP0005499_abnormal_olfactory_system | 1.69490362 |
| 32 | MP0002398_abnormal_bone_marrow | 1.67762193 |
| 33 | MP0004858_abnormal_nervous_system | 1.66467537 |
| 34 | MP0005451_abnormal_body_composition | 1.65838367 |
| 35 | MP0008260_abnormal_autophagy | 1.62355547 |
| 36 | MP0004510_myositis | 1.62171584 |
| 37 | MP0000716_abnormal_immune_system | 1.55450100 |
| 38 | MP0004947_skin_inflammation | 1.45505982 |
| 39 | MP0003693_abnormal_embryo_hatching | 1.41698111 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.40782937 |
| 41 | MP0002429_abnormal_blood_cell | 1.39840833 |
| 42 | MP0003787_abnormal_imprinting | 1.39487720 |
| 43 | MP0005423_abnormal_somatic_nervous | 1.37407186 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.36032595 |
| 45 | MP0002722_abnormal_immune_system | 1.34962800 |
| 46 | MP0010030_abnormal_orbit_morphology | 1.31633129 |
| 47 | MP0003172_abnormal_lysosome_physiology | 1.26861225 |
| 48 | MP0002405_respiratory_system_inflammati | 1.26105815 |
| 49 | MP0002132_abnormal_respiratory_system | 1.26021895 |
| 50 | MP0005464_abnormal_platelet_physiology | 1.23306008 |
| 51 | MP0008789_abnormal_olfactory_epithelium | 1.21919282 |
| 52 | MP0003878_abnormal_ear_physiology | 1.21069515 |
| 53 | MP0005377_hearing/vestibular/ear_phenot | 1.21069515 |
| 54 | MP0003111_abnormal_nucleus_morphology | 1.16515877 |
| 55 | MP0003763_abnormal_thymus_physiology | 1.15304916 |
| 56 | MP0003123_paternal_imprinting | 1.14447236 |
| 57 | MP0003075_altered_response_to | 1.13715952 |
| 58 | MP0009379_abnormal_foot_pigmentation | 1.13655109 |
| 59 | MP0001845_abnormal_inflammatory_respons | 1.12177636 |
| 60 | MP0000703_abnormal_thymus_morphology | 1.11493247 |
| 61 | MP0000750_abnormal_muscle_regeneration | 1.09205865 |
| 62 | MP0000858_altered_metastatic_potential | 1.09051319 |
| 63 | MP0000604_amyloidosis | 1.08224857 |
| 64 | MP0003122_maternal_imprinting | 1.07659734 |
| 65 | MP0001853_heart_inflammation | 1.05868821 |
| 66 | MP0002139_abnormal_hepatobiliary_system | 1.04078894 |
| 67 | MP0009765_abnormal_xenobiotic_induced | 1.03394931 |
| 68 | MP0010155_abnormal_intestine_physiology | 1.02886459 |
| 69 | MP0003121_genomic_imprinting | 1.01587489 |
| 70 | MP0001663_abnormal_digestive_system | 1.01268485 |
| 71 | MP0003724_increased_susceptibility_to | 1.00815677 |
| 72 | MP0001348_abnormal_lacrimal_gland | 0.99219982 |
| 73 | MP0008469_abnormal_protein_level | 0.96582464 |
| 74 | MP0001533_abnormal_skeleton_physiology | 0.95965227 |
| 75 | MP0006035_abnormal_mitochondrial_morpho | 0.95015307 |
| 76 | MP0009764_decreased_sensitivity_to | 0.91574843 |
| 77 | MP0002163_abnormal_gland_morphology | 0.89898578 |
| 78 | MP0006082_CNS_inflammation | 0.88833390 |
| 79 | MP0003329_amyloid_beta_deposits | 0.87238547 |
| 80 | MP0002089_abnormal_postnatal_growth/wei | 0.85598856 |
| 81 | MP0000313_abnormal_cell_death | 0.84715944 |
| 82 | MP0003183_abnormal_peptide_metabolism | 0.82565809 |
| 83 | MP0000343_altered_response_to | 0.81922149 |
| 84 | MP0001727_abnormal_embryo_implantation | 0.77597894 |
| 85 | MP0004859_abnormal_synaptic_plasticity | 0.74286626 |
| 86 | MP0010094_abnormal_chromosome_stability | 0.73691878 |
| 87 | MP0009672_abnormal_birth_weight | 0.73537457 |
| 88 | MP0002019_abnormal_tumor_incidence | 0.72636501 |
| 89 | MP0003806_abnormal_nucleotide_metabolis | 0.72146873 |
| 90 | MP0004133_heterotaxia | 0.71161282 |
| 91 | MP0009763_increased_sensitivity_to | 0.68043356 |
| 92 | MP0005257_abnormal_intraocular_pressure | 0.66970824 |
| 93 | MP0004808_abnormal_hematopoietic_stem | 0.66212210 |
| 94 | MP0002998_abnormal_bone_remodeling | 0.65896254 |
| 95 | MP0003186_abnormal_redox_activity | 0.65356987 |
| 96 | MP0005084_abnormal_gallbladder_morpholo | 0.64829637 |
| 97 | MP0000751_myopathy | 0.64529284 |
| 98 | MP0001542_abnormal_bone_strength | 0.60838688 |
| 99 | MP0006036_abnormal_mitochondrial_physio | 0.60728302 |
| 100 | MP0001730_embryonic_growth_arrest | 0.59486090 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.46332481 |
| 2 | Panhypogammaglobulinemia (HP:0003139) | 3.41123884 |
| 3 | Agammaglobulinemia (HP:0004432) | 3.32599921 |
| 4 | Reticulocytopenia (HP:0001896) | 3.29652570 |
| 5 | Thoracic kyphosis (HP:0002942) | 3.23224219 |
| 6 | Increased IgM level (HP:0003496) | 3.04841094 |
| 7 | Hyperacusis (HP:0010780) | 2.99336384 |
| 8 | Colitis (HP:0002583) | 2.93500214 |
| 9 | Multiple enchondromatosis (HP:0005701) | 2.93390477 |
| 10 | Progressive external ophthalmoplegia (HP:0000590) | 2.93110566 |
| 11 | Gastrointestinal stroma tumor (HP:0100723) | 2.90093683 |
| 12 | Cellulitis (HP:0100658) | 2.85416243 |
| 13 | Ragged-red muscle fibers (HP:0003200) | 2.83436807 |
| 14 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.81387612 |
| 15 | Personality changes (HP:0000751) | 2.79022021 |
| 16 | Obstructive lung disease (HP:0006536) | 2.72202181 |
| 17 | Chronic obstructive pulmonary disease (HP:0006510) | 2.72202181 |
| 18 | Lymphopenia (HP:0001888) | 2.71502961 |
| 19 | Mediastinal lymphadenopathy (HP:0100721) | 2.71382876 |
| 20 | Meningitis (HP:0001287) | 2.70559756 |
| 21 | IgM deficiency (HP:0002850) | 2.68467573 |
| 22 | Upper motor neuron abnormality (HP:0002127) | 2.68294604 |
| 23 | Progressive muscle weakness (HP:0003323) | 2.68255043 |
| 24 | Overriding aorta (HP:0002623) | 2.63712549 |
| 25 | Long palpebral fissure (HP:0000637) | 2.52161200 |
| 26 | Gastrointestinal inflammation (HP:0004386) | 2.46934239 |
| 27 | Myokymia (HP:0002411) | 2.46779994 |
| 28 | Abnormal number of erythroid precursors (HP:0012131) | 2.45962562 |
| 29 | Recurrent viral infections (HP:0004429) | 2.44552250 |
| 30 | Turricephaly (HP:0000262) | 2.44474249 |
| 31 | Abnormality of the thoracic spine (HP:0100711) | 2.41259296 |
| 32 | Disinhibition (HP:0000734) | 2.40358873 |
| 33 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.37951200 |
| 34 | Choanal stenosis (HP:0000452) | 2.37197865 |
| 35 | Abnormality of macrophages (HP:0004311) | 2.35208656 |
| 36 | Hypertensive crisis (HP:0100735) | 2.32380121 |
| 37 | Microvesicular hepatic steatosis (HP:0001414) | 2.27878517 |
| 38 | Inflammation of the large intestine (HP:0002037) | 2.25773872 |
| 39 | Cholecystitis (HP:0001082) | 2.25384101 |
| 40 | Abnormal gallbladder physiology (HP:0012438) | 2.25384101 |
| 41 | Poikiloderma (HP:0001029) | 2.24351099 |
| 42 | Polygenic inheritance (HP:0010982) | 2.24229542 |
| 43 | Abnormality of reticulocytes (HP:0004312) | 2.23304363 |
| 44 | Petechiae (HP:0000967) | 2.23275800 |
| 45 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.20398550 |
| 46 | Insomnia (HP:0100785) | 2.18667060 |
| 47 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.17456742 |
| 48 | Increased muscle lipid content (HP:0009058) | 2.14753506 |
| 49 | Broad distal phalanx of finger (HP:0009836) | 2.13780212 |
| 50 | Deep palmar crease (HP:0006191) | 2.13334074 |
| 51 | Pallor (HP:0000980) | 2.12345623 |
| 52 | Eczematoid dermatitis (HP:0000976) | 2.11627079 |
| 53 | Increased IgE level (HP:0003212) | 2.10946520 |
| 54 | Systemic lupus erythematosus (HP:0002725) | 2.10416517 |
| 55 | Myopathic facies (HP:0002058) | 2.10123460 |
| 56 | Elfin facies (HP:0004428) | 2.09813059 |
| 57 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.08301289 |
| 58 | Recurrent fungal infections (HP:0002841) | 2.07941345 |
| 59 | Recurrent sinusitis (HP:0011108) | 2.06619200 |
| 60 | Annular pancreas (HP:0001734) | 2.06613657 |
| 61 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.05230534 |
| 62 | Prolonged neonatal jaundice (HP:0006579) | 2.05072333 |
| 63 | Recurrent abscess formation (HP:0002722) | 2.04770254 |
| 64 | Dysphonia (HP:0001618) | 2.02354496 |
| 65 | Neuronal loss in central nervous system (HP:0002529) | 2.02201140 |
| 66 | Pointed chin (HP:0000307) | 2.00979186 |
| 67 | Achilles tendon contracture (HP:0001771) | 1.99539591 |
| 68 | Abnormality of lateral ventricle (HP:0030047) | 1.98664295 |
| 69 | Thrombocytosis (HP:0001894) | 1.98631979 |
| 70 | Trigonocephaly (HP:0000243) | 1.95905315 |
| 71 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.95379006 |
| 72 | Vacuolated lymphocytes (HP:0001922) | 1.95167425 |
| 73 | Increased cerebral lipofuscin (HP:0011813) | 1.94087985 |
| 74 | Hepatosplenomegaly (HP:0001433) | 1.94004592 |
| 75 | Abnormal neuron morphology (HP:0012757) | 1.92119403 |
| 76 | Abnormality of the motor neurons (HP:0002450) | 1.92119403 |
| 77 | IgG deficiency (HP:0004315) | 1.91777490 |
| 78 | Impaired proprioception (HP:0010831) | 1.91201441 |
| 79 | Emphysema (HP:0002097) | 1.89996650 |
| 80 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.89493124 |
| 81 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.89493124 |
| 82 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.89231156 |
| 83 | Recurrent lower respiratory tract infections (HP:0002783) | 1.88204033 |
| 84 | Encephalitis (HP:0002383) | 1.87532240 |
| 85 | Recurrent bacterial skin infections (HP:0005406) | 1.84953266 |
| 86 | IgA deficiency (HP:0002720) | 1.83664011 |
| 87 | Increased intramyocellular lipid droplets (HP:0012240) | 1.83611342 |
| 88 | Squamous cell carcinoma (HP:0002860) | 1.80376853 |
| 89 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.78941426 |
| 90 | Retinal dysplasia (HP:0007973) | 1.78306552 |
| 91 | Premature loss of primary teeth (HP:0006323) | 1.78282503 |
| 92 | Vasculitis (HP:0002633) | 1.77862286 |
| 93 | Acute hepatic failure (HP:0006554) | 1.77667223 |
| 94 | Metaphyseal cupping (HP:0003021) | 1.76785460 |
| 95 | Renal duplication (HP:0000075) | 1.75655689 |
| 96 | Basal cell carcinoma (HP:0002671) | 1.74902809 |
| 97 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.74809983 |
| 98 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.73583994 |
| 99 | Reticulocytosis (HP:0001923) | 1.72928896 |
| 100 | Spastic diplegia (HP:0001264) | 1.72206742 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.63943714 |
| 2 | NME2 | 3.37832534 |
| 3 | SMG1 | 3.35921805 |
| 4 | BCKDK | 2.95183878 |
| 5 | MAP3K11 | 2.75601061 |
| 6 | TESK2 | 2.74150025 |
| 7 | VRK2 | 2.41488151 |
| 8 | ARAF | 2.24032561 |
| 9 | PRPF4B | 2.21028898 |
| 10 | RIPK4 | 2.16781549 |
| 11 | MAP3K10 | 2.16609105 |
| 12 | CDK19 | 2.07716361 |
| 13 | EEF2K | 1.96169903 |
| 14 | PIM2 | 1.79049696 |
| 15 | CDC7 | 1.65035749 |
| 16 | TAOK2 | 1.62757392 |
| 17 | TBK1 | 1.59983954 |
| 18 | STK16 | 1.54555736 |
| 19 | TRIB3 | 1.48405769 |
| 20 | ERN1 | 1.43867798 |
| 21 | FES | 1.42610682 |
| 22 | KDR | 1.31878460 |
| 23 | TNK2 | 1.27041800 |
| 24 | DYRK2 | 1.22942619 |
| 25 | TESK1 | 1.16506902 |
| 26 | SIK1 | 1.13944726 |
| 27 | RPS6KA4 | 1.12413632 |
| 28 | CDK9 | 1.11591019 |
| 29 | MATK | 1.05324715 |
| 30 | PASK | 1.04985173 |
| 31 | MAP3K13 | 1.04232521 |
| 32 | MAP3K14 | 1.02183377 |
| 33 | CSF1R | 1.02116393 |
| 34 | TYRO3 | 1.00946836 |
| 35 | DAPK3 | 0.99608863 |
| 36 | RPS6KC1 | 0.98691117 |
| 37 | RPS6KL1 | 0.98691117 |
| 38 | KIT | 0.98159221 |
| 39 | LRRK2 | 0.94392851 |
| 40 | CDK4 | 0.94365161 |
| 41 | RPS6KA2 | 0.93121805 |
| 42 | PRKD3 | 0.91712846 |
| 43 | FGR | 0.88216265 |
| 44 | MAP2K3 | 0.88129427 |
| 45 | BRAF | 0.87423290 |
| 46 | MAP3K9 | 0.87113711 |
| 47 | SIK2 | 0.85624689 |
| 48 | BLK | 0.82656427 |
| 49 | DYRK3 | 0.81460162 |
| 50 | TGFBR1 | 0.80238217 |
| 51 | BMX | 0.79503174 |
| 52 | CDK14 | 0.77460163 |
| 53 | IKBKE | 0.76916520 |
| 54 | RPS6KA6 | 0.76313824 |
| 55 | FGFR4 | 0.75558476 |
| 56 | CDK11A | 0.75335855 |
| 57 | IKBKB | 0.75279028 |
| 58 | SYK | 0.74507450 |
| 59 | VRK1 | 0.73602849 |
| 60 | CDK15 | 0.70681160 |
| 61 | NME1 | 0.70236619 |
| 62 | RPS6KB2 | 0.70210723 |
| 63 | CDC42BPA | 0.70050375 |
| 64 | MAP3K1 | 0.70005822 |
| 65 | MARK2 | 0.69686313 |
| 66 | AURKA | 0.69133945 |
| 67 | BTK | 0.67867842 |
| 68 | MAP3K8 | 0.67865696 |
| 69 | PIM1 | 0.67523190 |
| 70 | IRAK4 | 0.66740301 |
| 71 | TAOK1 | 0.66724615 |
| 72 | PKN2 | 0.66482525 |
| 73 | CDK8 | 0.65545416 |
| 74 | MARK3 | 0.65033998 |
| 75 | CSNK1G3 | 0.63404826 |
| 76 | TAF1 | 0.61745062 |
| 77 | CDK18 | 0.61547023 |
| 78 | TYK2 | 0.61089229 |
| 79 | ALK | 0.61084497 |
| 80 | DAPK1 | 0.60488640 |
| 81 | DDR2 | 0.58372469 |
| 82 | CSK | 0.55863005 |
| 83 | RPS6KA5 | 0.55579100 |
| 84 | IRAK3 | 0.53548370 |
| 85 | HIPK2 | 0.53254012 |
| 86 | SCYL2 | 0.53228583 |
| 87 | ICK | 0.52105186 |
| 88 | GRK6 | 0.51706754 |
| 89 | RPS6KA1 | 0.51646321 |
| 90 | LYN | 0.51185531 |
| 91 | DYRK1B | 0.48800762 |
| 92 | CDK7 | 0.48061891 |
| 93 | MOS | 0.45612877 |
| 94 | PRKCQ | 0.43140340 |
| 95 | PAK1 | 0.43003761 |
| 96 | LCK | 0.40646456 |
| 97 | CSNK1A1L | 0.40616747 |
| 98 | SIK3 | 0.39376901 |
| 99 | LIMK1 | 0.36240528 |
| 100 | CHEK2 | 0.34468255 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur relay system_Homo sapiens_hsa04122 | 3.94043428 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.59052391 |
| 3 | Base excision repair_Homo sapiens_hsa03410 | 2.82257418 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.80462399 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 2.68031366 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.44317630 |
| 7 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.30926934 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.25000135 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.19254711 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.15350049 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.13255477 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.11890312 |
| 13 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.04571549 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 2.02227846 |
| 15 | Asthma_Homo sapiens_hsa05310 | 1.92063757 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.83827097 |
| 17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.63684733 |
| 18 | Leishmaniasis_Homo sapiens_hsa05140 | 1.63489701 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.61624636 |
| 20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.54913266 |
| 21 | Carbon metabolism_Homo sapiens_hsa01200 | 1.50697322 |
| 22 | Spliceosome_Homo sapiens_hsa03040 | 1.47676667 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.47325566 |
| 24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.46921469 |
| 25 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.37219205 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.36479691 |
| 27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.32740117 |
| 28 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.30801327 |
| 29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.30268487 |
| 30 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.27353028 |
| 31 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.26696237 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.26221969 |
| 33 | Galactose metabolism_Homo sapiens_hsa00052 | 1.24666765 |
| 34 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.20879617 |
| 35 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.19771072 |
| 36 | Mismatch repair_Homo sapiens_hsa03430 | 1.15796277 |
| 37 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.15731972 |
| 38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.15514092 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.12525426 |
| 40 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.10903776 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.09372262 |
| 42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.09186848 |
| 43 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.08366646 |
| 44 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.07012242 |
| 45 | Tuberculosis_Homo sapiens_hsa05152 | 1.03372299 |
| 46 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.02124678 |
| 47 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.99202965 |
| 48 | Apoptosis_Homo sapiens_hsa04210 | 0.98714816 |
| 49 | Lysosome_Homo sapiens_hsa04142 | 0.91834369 |
| 50 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.91449871 |
| 51 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.87309460 |
| 52 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.86463687 |
| 53 | Salmonella infection_Homo sapiens_hsa05132 | 0.85770784 |
| 54 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.85020803 |
| 55 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.83460730 |
| 56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.81069153 |
| 57 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.78668643 |
| 58 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.75947169 |
| 59 | Prion diseases_Homo sapiens_hsa05020 | 0.74740886 |
| 60 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.74606926 |
| 61 | Hepatitis C_Homo sapiens_hsa05160 | 0.73528916 |
| 62 | HTLV-I infection_Homo sapiens_hsa05166 | 0.72733276 |
| 63 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.71042033 |
| 64 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.70254893 |
| 65 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69867519 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.69479505 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68873875 |
| 68 | Bladder cancer_Homo sapiens_hsa05219 | 0.64897829 |
| 69 | Hepatitis B_Homo sapiens_hsa05161 | 0.64432550 |
| 70 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56849603 |
| 71 | Pertussis_Homo sapiens_hsa05133 | 0.56742724 |
| 72 | Phagosome_Homo sapiens_hsa04145 | 0.53175449 |
| 73 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.52979875 |
| 74 | Measles_Homo sapiens_hsa05162 | 0.51179645 |
| 75 | Parkinsons disease_Homo sapiens_hsa05012 | 0.49027724 |
| 76 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.48422240 |
| 77 | Alcoholism_Homo sapiens_hsa05034 | 0.48196706 |
| 78 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.47781262 |
| 79 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.46933491 |
| 80 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.44740315 |
| 81 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.44526588 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43991251 |
| 83 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.43936411 |
| 84 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.43536074 |
| 85 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42578548 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41859550 |
| 87 | RNA transport_Homo sapiens_hsa03013 | 0.41743711 |
| 88 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.40624900 |
| 89 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.40536620 |
| 90 | RNA polymerase_Homo sapiens_hsa03020 | 0.40464703 |
| 91 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.39923479 |
| 92 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.39586626 |
| 93 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.37634642 |
| 94 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.36160384 |
| 95 | Legionellosis_Homo sapiens_hsa05134 | 0.35103129 |
| 96 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.34283218 |
| 97 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.34223035 |
| 98 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.33059923 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31810247 |
| 100 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.31603434 |

